The backing from the European Union drug watchdog's committee comes two days after Wegovy secured a similar nod from the UK regulator, while the U.S. Food and Drug Administration approved the drug for prevention of cardiovascular events in people with obesity earlier this year.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/6pLMDoF
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment